Results showed that Nppa expression was significantly higher in the TAC group than in the Sham group, and treatment with FICZ significantly decreased Nppa expression in the TAC group to levels close to those in the Sham group (Figure 4A). This evidence concerns the gene NPPA and persistent truncus arteriosus.